AASLD 2018 Hepatitis B Guidance on Immunosuppressive Therapy
AASLD 2018 乙肝指导中关于免疫抑制或细胞毒性治疗相关 HBV 再激活预防、筛查、预防性抗病毒治疗和监测的建议。
HBV Follow-up Planning Tool
Choose common situations to generate an educational clinic-preparation checklist. This tool organizes questions only and does not decide treatment.
What it helps organize
- Place HBV DNA, ALT/AST, liver function, ultrasound, AFP, elastography, and medication records in one follow-up checklist.
- Highlight topics to confirm with a clinician when cirrhosis, pregnancy, immunosuppression, or liver cancer family history is relevant.
- Flag symptoms that should not wait for routine follow-up.
Evidence sources
AASLD Practice Guidance on Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma
AASLD 关于肝细胞癌预防、诊断和治疗的实践指导，包含高风险人群监测、超声联合 AFP、约每 6 个月监测和异常结果后进一步诊断评估等建议。
CDC 2023 Hepatitis B Screening and Testing Recommendations
CDC 2023 年乙肝筛查和检测建议，包含成人一次性三项筛查，以及接受或需要细胞毒性、免疫抑制或免疫调节治疗人群的检测建议。
Hepatitis B Online Choosing an Initial HBV Treatment Regimen
面向临床学习者的慢性乙肝初始治疗方案说明，比较恩替卡韦、TDF、TAF 等药物，并讨论肾功能、骨密度、妊娠和合并疾病等用药安全考虑。
Hepatitis B Online Monitoring Persons On and Off HBV Therapy
面向临床学习者的慢性乙肝治疗前后监测说明，涵盖 ALT、HBV DNA、HBeAg/HBsAg 和肝癌筛查等随访项目。
WHO 2024 Chronic Hepatitis B Guidelines
WHO 2024 年慢性乙肝预防、诊断、照护和治疗指南，覆盖检测、治疗、随访和公共卫生策略。